-
Today’s Watch List: Regulus Therapeutics Inc. (NASDAQ:RGLS), Numerex Corp. (NASDAQ:NMRX), ORIX Corporation (NYSE:IX), FelCor Lodging Trust Incorporated (NYSE:FCH), Crown Castle International (NYSE:CCI)
On Friday shares of Regulus Therapeutics Inc. (NASDAQ:RGLS) closed at $12.44. Company’s EPS growth for next 5 years is recorded as 39.60%. Regulus Therapeutics Inc. (NASDAQ:RGLS) on May 07, reported a loss of $14.5 million in its first quarter. The San Diego-based company said it had a loss of 29 cents per share. Losses, adjusted […]
-
Morning Alert: Regulus Therapeutics Inc. (NASDAQ:RGLS), The Home Depot (NYSE:HD), Health Net (NYSE:HNT), Monster Beverage (NASDAQ:MNST), Marcus & Millichap (NYSE:MMI)
On Friday shares of Regulus Therapeutics Inc. (NASDAQ:RGLS) closed at $13.83. Company’s EPS growth for next 5 years is recorded as 39.60%. Zacks upgraded shares of Regulus Therapeutics (NASDAQ:RGLS) from a hold rating to a buy rating in a report issued on Thursday. They currently have $15.00 target price on the stock. The Home Depot, […]
-
Morning Alert: Regulus Therapeutics Inc. (NASDAQ:RGLS), Genetic Technologies Limited (NASDAQ:GENE), Google Inc (NASDAQ:GOOG), Universal Stainless & Alloy Products (NASDAQ:USAP), Ford Motor (NYSE:F)
On Thursday shares of Regulus Therapeutics Inc. (NASDAQ:RGLS) closed at $13.01. Company’s EPS growth for next 5 years is recorded as 39.60%. Regulus Therapeutics Inc. (NASDAQ:RGLS) reported financial results for the first quarter ended March 31, 2015, including a summary of recent corporate highlights. Company recognized revenue of $4.2 million for the quarter ended March […]
-
Best Stocks: Regulus Therapeutics Inc. (NASDAQ:RGLS), Alnylam Pharmaceuticals (NASDAQ:ALNY), LDR Holding Corporation (NASDAQ:LDRH), Knowles Corporation (NYSE:KN), Buffalo Wild Wings Inc. (NASDAQ:BWLD)
On Friday shares of Regulus Therapeutics Inc. (NASDAQ:RGLS) closed at $17.49. Company’s EPS growth for next 5 years is recorded as 39.60%. Regulus Therapeutics Inc. (NASDAQ:RGLS) presented new data strengthening the profile of RG-101, a wholly-owned, GalNAc-conjugated anti-miR targeting microRNA-122 (“miR-122”) for the treatment of HCV, during an oral late-breaking session at ILC 2015 in […]
-
Don’t Miss: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Regulus Therapeutics Inc. (NASDAQ:RGLS), American Realty Capital Properties (NASDAQ:ARCP), Sony (NYSE:SNE), Central Garden & Pet (NASDAQ:CENT)
On Friday shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) closed at $37.53. Company’s sales growth for last 5 years was -56.50% and EPS growth for next 5 years is recorded as 20.00%. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) announced that it will present at the 14th Annual Needham Healthcare Conference on Tuesday April 14 2015 at 9:20 a.m. […]
-
Investors Watch List: Regulus Therapeutics Inc. (NASDAQ:RGLS), Orexigen Therapeutics (NASDAQ:OREX), Ohr Pharmaceutical (NASDAQ:OHRP), 3M Company (NYSE:MMM)
On Monday shares of Regulus Therapeutics Inc. (NASDAQ:RGLS) closed at $17.26. Company’s EPS growth for next 5 years is recorded as 39.60%. Regulus Therapeutics Inc. (NASDAQ:RGLS) ‘s stock had its “outperform” rating reissued by research analysts at Wedbush in a report released on Wednesday. They currently have a $41.00 price objective on the stock. Wedbush’s […]
-
Notable Ups And Down: Regulus Therapeutics Inc. (NASDAQ:RGLS), Pfizer Inc. (NYSE:PFE), Petroleo Brasileiro Petrobras (NYSE:PBR), Teck Resources (NYSE:TCK), Darden Restaurants (NYSE:DRI)
Analysts at Wedbush gave Regulus Therapeutics Inc. (NASDAQ:RGLS) an “outperform” rating.On Tuesday shares of Regulus Therapeutics Inc. (NASDAQ:RGLS) closed at $19.62. Company’s EPS growth for next 5 years is recorded as 39.60%. On 5 March 2015, Pfizer Inc. (NYSE:PFE) announced that Prevenar 13 was approved in the EU for the prevention of pneumonia caused by […]
-
Best Stocks: Coffee Holding Company (NASDAQ:JVA), Regulus Therapeutics Inc. (NASDAQ:RGLS), Heat Biologics (NASDAQ:HTBX), Crestwood Midstream Partners (NYSE:CMLP), Gran Tierra Energy (NYSEMKT:GTE)
On Mar 6, Coffee Holding Company, Inc. (NASDAQ:JVA) announced its operating results for the three months ended January 31, 2015: The Company reported net income of $71,801, or $0.01 per share basic and diluted, for the three months ended January 31, 2015, compared to net income of $1,371,740 or $0.22 per share basic and $0.21 […]
-
Mix Sector Stocks: Geron Corporation (NASDAQ:GERN), Regulus Therapeutics Inc. (NASDAQ:RGLS), Oculus Innovative Sciences (NASDAQ:OCLS), FEI Company (NASDAQ:FEIC), ARM Holdings plc (NASDAQ:ARMH)
On March 3, Geron Corp (NASDAQ:GERN) reported Q4 EPS of ($0.06), versus ($0.07) reported last year. Revenue for the quarter came in at $178 million, versus $225 million reported last year. On Friday shares of Geron Corporation (NASDAQ:GERN) closed at $3.50. Company’s sales growth for last 5 years was -14.20% and EPS growth for next […]
-
Stocks Buzz: Vodafone Group Plc (ADR) (NASDAQ:VOD), Regulus Therapeutics Inc. (NASDAQ:RGLS), Tecumseh Products Company (NASDAQ:TECU), Morgan Stanley (NYSE:MS), AutoZone (NYSE:AZO)
Vodafone Group PLC (ADR) (NASDAQ:VOD) said its M-Pesa mobile money transfer and payment service has launched its first international money transfer corridor between Tanzania and Kenya. M-Pesa customers in these countries can now use their mobile phones for money transfers between countries via a combined network of 180,000 agents. Vodafone claims its service is cheaper […]